PhRMA head Steve Ubl to step down at end of yearnews2026-04-08T16:15:29+00:00April 8th, 2026|Endpoints News|
Merck adjusts its vaccine supply deal in China; Soleno withdraws EU applicationnews2026-04-08T15:24:21+00:00April 8th, 2026|Endpoints News|
Gilead takes another big swing at expanding beyond HIVnews2026-04-08T15:10:43+00:00April 8th, 2026|Endpoints News|
Inside the Talkspace-Universal Health Services dealnews2026-04-08T14:23:54+00:00April 8th, 2026|Endpoints News|
David Sinclair startup Life Biosciences raises $80M for clinical test of anti-aging gene therapynews2026-04-08T12:00:17+00:00April 8th, 2026|Endpoints News|
ADC biotech Sidewinder collects $137M for bispecific approachnews2026-04-08T11:00:04+00:00April 8th, 2026|Endpoints News|
Insmed shelves Brinsupri in skin disease after mid-stage flopnews2026-04-08T10:06:51+00:00April 8th, 2026|Endpoints News|
European VC Jeito gets $1.2B to help private biotechs control their ‘destiny’news2026-04-08T07:16:52+00:00April 8th, 2026|Endpoints News|
Did Eli Lilly just strike another gold mine?news2026-04-07T19:29:41+00:00April 7th, 2026|Endpoints News|
What’s familiar in health tech’s Q1 funding totalsnews2026-04-07T19:25:14+00:00April 7th, 2026|Endpoints News|
